Brussels-based trade association founded in 1978 representing the biopharmaceutical industry operating in Europe.
Through the direct membership of 37 national associations, 38 leading pharmaceutical companies and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment for members to innovate, discover, develop, and deliver new therapies and vaccines for people across Europe, and to contribute to the European economy.
Figures provided by the European Commission in 2021 show that, according to the companies included in its scoreboard, health industries spend 19.9 per cent on research and development in Europe.
The pharmaceutical industry’s key contribution to medical progress is to transform fundamental research into innovative treatments that are widely available and accessible to patients, with the aim of helping people live longer and be healthier. However, huge challenges remain in many disease areas such as Alzheimer’s, multiple sclerosis, many cancers, and orphan diseases.